Razadyne ER 16 mg 24HR Extended Release Oral Capsule
RxNorm 860697
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 860697 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Razadyne ER 16 mg 24HR Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
24 HR galantamine hydrobromide 16 mg Extended Release Oral Capsule [Razadyne]
(Atom ID: 6353040)
SY
Synonym (SY):
24 HR Razadyne ER 16 mg Extended Release Oral Capsule
(Atom ID: 6356227)
SY
Synonym (SY):
Razadyne ER 16 mg 24 HR Extended Release Oral Capsule
(Atom ID: 6356571)
PSN
Prescribable Name (PSN):
Razadyne ER 16 mg 24HR Extended Release Oral Capsule
(Atom ID: 6371573)
Patient Education
Galantamine
Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future.
[Learn More]
* Please review the disclaimer below.